WO2005123123A3 - Reprogrammation therapeutique, cellules souches hybrides et maturation - Google Patents
Reprogrammation therapeutique, cellules souches hybrides et maturation Download PDFInfo
- Publication number
- WO2005123123A3 WO2005123123A3 PCT/US2005/005052 US2005005052W WO2005123123A3 WO 2005123123 A3 WO2005123123 A3 WO 2005123123A3 US 2005005052 W US2005005052 W US 2005005052W WO 2005123123 A3 WO2005123123 A3 WO 2005123123A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cells
- stem cells
- maturation
- therapeutically
- therapeutic reprogramming
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0608—Germ cells
- C12N5/061—Sperm cells, spermatogonia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/06—Anti-neoplasic drugs, anti-retroviral drugs, e.g. azacytidine, cyclophosphamide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/02—Coculture with; Conditioned medium produced by embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/04—Cells produced using nuclear transfer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0511889-1A BRPI0511889A (pt) | 2004-06-08 | 2005-02-16 | reprogramação terapêutica, células-tronco hìbridas e maturação |
AU2005253923A AU2005253923A1 (en) | 2004-06-08 | 2005-02-16 | Therapeutic reprogramming, hybrid stem cells and maturation |
RU2006147263/14A RU2006147263A (ru) | 2004-06-08 | 2005-02-16 | Терапевтическое перепрограммирование, гибридные стволовые клетки и созревание |
EP05723204A EP1758989A2 (fr) | 2004-06-08 | 2005-02-16 | Reprogrammation therapeutique, cellules souches hybrides et maturation |
CA002567692A CA2567692A1 (fr) | 2004-06-08 | 2005-02-16 | Reprogrammation therapeutique, cellules souches hybrides et maturation |
JP2007527196A JP2008501795A (ja) | 2004-06-08 | 2005-02-16 | ハイブリッド幹細胞の治療的再プログラミングおよび成熟 |
IL179927A IL179927A0 (en) | 2004-06-08 | 2006-12-07 | Therapeutic reprogramming, hybrid stem cells and maturation |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/864,788 | 2004-06-08 | ||
US10/864,788 US20050090004A1 (en) | 2003-01-16 | 2004-06-08 | Stem cell maturation for all tissue lines |
US58814604P | 2004-07-15 | 2004-07-15 | |
US60/588,146 | 2004-07-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005123123A2 WO2005123123A2 (fr) | 2005-12-29 |
WO2005123123A3 true WO2005123123A3 (fr) | 2006-03-02 |
Family
ID=35355246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/005052 WO2005123123A2 (fr) | 2004-06-08 | 2005-02-16 | Reprogrammation therapeutique, cellules souches hybrides et maturation |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1758989A2 (fr) |
JP (1) | JP2008501795A (fr) |
AU (1) | AU2005253923A1 (fr) |
BR (1) | BRPI0511889A (fr) |
CA (1) | CA2567692A1 (fr) |
RU (1) | RU2006147263A (fr) |
WO (1) | WO2005123123A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5491871B2 (ja) | 2007-02-28 | 2014-05-14 | アドビナス セラピュティックス プライベート リミテッド | グルコキナーゼ活性化因子としての2,2,2−三置換アセトアミド誘導体、その方法及び薬学的応用 |
EP2155720B1 (fr) | 2007-06-08 | 2013-07-17 | Advinus Therapeutics Private Limited | Nouveaux dérivés de pyrrole-2-carboxamide en tant qu'activateurs de la glucokinase, leur procédé d'obtention et leur application pharmaceutique |
EP2090649A1 (fr) | 2008-02-13 | 2009-08-19 | Fondazione Telethon | Procédé de reprogrammation de cellules différentiées |
EP2402327B1 (fr) | 2010-06-29 | 2018-03-07 | Impetis Biosciences Ltd. | Composés d'acétamide en tant qu'activateurs de la glucokinase, leur procédé et applications médicales |
EP2796873A1 (fr) * | 2013-04-25 | 2014-10-29 | QGel SA | Procédé pour un test de criblage de médicaments à base de cellules et son utilisation |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000006701A1 (fr) * | 1998-07-31 | 2000-02-10 | Genzyme Corporation | Amelioration du fonctionnement cardiaque par transplantation de cellules souches mesenchymateuses |
WO2002051980A2 (fr) * | 2000-12-12 | 2002-07-04 | Nucleus Remodeling, Inc. | Cellules souches adultes multipotentes derivees in vitro et leurs utilisations |
WO2003027278A1 (fr) * | 2001-09-21 | 2003-04-03 | Reprocell Inc. | Cellules souches multifonctionnelles adaptees et utilisation de ces dernieres |
WO2003062384A2 (fr) * | 2002-01-16 | 2003-07-31 | Chauncey Sayre | Maturation de cellules souches pour tous les types de tissus |
WO2003102126A1 (fr) * | 2002-05-31 | 2003-12-11 | Apollo Life Sciences Pty Ltd | Methode de therapie cellulaire faisant appel a des hybrides cellulaires fusionnes |
WO2004046312A2 (fr) * | 2002-11-15 | 2004-06-03 | The Board Of Trustees Of The University Of Illinois | Methodes de developpement in vitro de cellules souches hematopoietiques |
-
2005
- 2005-02-16 CA CA002567692A patent/CA2567692A1/fr not_active Abandoned
- 2005-02-16 JP JP2007527196A patent/JP2008501795A/ja not_active Withdrawn
- 2005-02-16 AU AU2005253923A patent/AU2005253923A1/en not_active Abandoned
- 2005-02-16 EP EP05723204A patent/EP1758989A2/fr not_active Withdrawn
- 2005-02-16 WO PCT/US2005/005052 patent/WO2005123123A2/fr active Application Filing
- 2005-02-16 RU RU2006147263/14A patent/RU2006147263A/ru unknown
- 2005-02-16 BR BRPI0511889-1A patent/BRPI0511889A/pt not_active IP Right Cessation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000006701A1 (fr) * | 1998-07-31 | 2000-02-10 | Genzyme Corporation | Amelioration du fonctionnement cardiaque par transplantation de cellules souches mesenchymateuses |
WO2002051980A2 (fr) * | 2000-12-12 | 2002-07-04 | Nucleus Remodeling, Inc. | Cellules souches adultes multipotentes derivees in vitro et leurs utilisations |
WO2003027278A1 (fr) * | 2001-09-21 | 2003-04-03 | Reprocell Inc. | Cellules souches multifonctionnelles adaptees et utilisation de ces dernieres |
EP1437404A1 (fr) * | 2001-09-21 | 2004-07-14 | ReproCELL Inc. | Cellules souches multifonctionnelles adaptees et utilisation de ces dernieres |
WO2003062384A2 (fr) * | 2002-01-16 | 2003-07-31 | Chauncey Sayre | Maturation de cellules souches pour tous les types de tissus |
WO2003102126A1 (fr) * | 2002-05-31 | 2003-12-11 | Apollo Life Sciences Pty Ltd | Methode de therapie cellulaire faisant appel a des hybrides cellulaires fusionnes |
WO2004046312A2 (fr) * | 2002-11-15 | 2004-06-03 | The Board Of Trustees Of The University Of Illinois | Methodes de developpement in vitro de cellules souches hematopoietiques |
Non-Patent Citations (5)
Title |
---|
DONOVAN P J & DE MIGUEL M P: "Turning germ cells into stem cells.", CURRENT OPINION IN GENETICS & DEVELOPMENT, vol. 13, no. 5, October 2003 (2003-10-01), pages 463 - 471, XP002355791, ISSN: 0959-437X * |
MOENS A ET AL: "Differential ability of male and female rabbit fetal germ cell nuclei to be reprogrammed by nuclear transfer.", DIFFERENTIATION, vol. 60, no. 5, September 1996 (1996-09-01), pages 339 - 345, XP002355344, ISSN: 0301-4681 * |
TADA M ET AL: "Embryonic germ cells induce epigenetic reprogramming of somatic nuclear in hybrid cells", EMBO JOURNAL, vol. 16, no. 21, 1997, pages 6510 - 6520, XP002960229, ISSN: 0261-4189 * |
TADA M ET AL: "Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells", CURRENT BIOLOGY, vol. 11, no. 19, 2 October 2001 (2001-10-02), pages 1553 - 1558, XP002960228, ISSN: 0960-9822 * |
YAMAZAKI Y ET AL: "Adult mice cloned from migrating primordial germ cells.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 102, no. 32, 9 August 2005 (2005-08-09), pages 11361 - 11366, XP002355792, ISSN: 0027-8424 * |
Also Published As
Publication number | Publication date |
---|---|
EP1758989A2 (fr) | 2007-03-07 |
AU2005253923A1 (en) | 2005-12-29 |
CA2567692A1 (fr) | 2005-12-29 |
JP2008501795A (ja) | 2008-01-24 |
WO2005123123A2 (fr) | 2005-12-29 |
BRPI0511889A (pt) | 2008-01-15 |
RU2006147263A (ru) | 2008-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007026255A3 (fr) | Cellules dedifferenciees et procedes permettant de realiser et d'utiliser des cellules dedifferenciees | |
EP1719196A4 (fr) | Materiaux d'electrodes actifs de batteries secondaires et procedes de fabrication associes | |
EP1746675A4 (fr) | Batterie secondaire ionique au lithium et procede de fabrication de ladite batterie | |
EP1689011A4 (fr) | Materiau d'electrode positive pour batterie secondaire, procede de production d'un tel materiau et batterie secondaire | |
IL179919A0 (en) | Neural stem cells, compositions containing the same and methods for promoting the division thereof | |
WO2008079997A3 (fr) | Mécanisme et procédé d'angiogenèse et dispositif implantable | |
EP2056380A4 (fr) | Matériau actif d'électrode négative pour batterie secondaire ion-lithium, procédé de production de celui-ci, électrode négative pour batterie secondaire ion-lithium utilisant celui-ci, et batterie secondaire ion-lithium | |
EP1808918A4 (fr) | Matériau d électrode positive pour batterie secondaire au lithium et procédé de fabrication dudit matériau | |
GB2431582B (en) | Dendritic cell vaccines made from embryonic stem cells for treating cancer | |
EP1812556A4 (fr) | Progeniteurs neuronaux obtenus par culture de cellules souches embryonnaires humaines sans cellules nourricieres | |
WO2007127927A3 (fr) | Différentiation de cellules souches embryonnaires humaines | |
EP2124273A4 (fr) | Electrode négative pour batterie secondaire au lithium et son procédé de production associé, et batterie secondaire au lithium comprenant une électrode négative pour batterie secondaire au lithium | |
EP2081243A4 (fr) | Matériau d'électrode négative pour une batterie secondaire lithium-ion et procédé de fabrication de celui-ci | |
WO2007056994A3 (fr) | Procede de production de lignees cellulaires humaines permanentes | |
WO2009012428A3 (fr) | Différenciation de cellules souches embryonnaires humaines | |
EP1981104A4 (fr) | Matériau d'électrode négative pour accumulateur à l'ion lithium et son procédé de production | |
IL184043A0 (en) | A method for enhancing cardiomyocyte differentiation, cell cultures for use therein and isolated cardiomyocytes produced thereby | |
WO2006074308A3 (fr) | Regeneration des ilots pancreatiques par traitement des cellules souches du liquide amniotique | |
EP1633807B8 (fr) | Matrice, implant cellulaire, leur procede de production et leur utilisation | |
WO2006074075A3 (fr) | Cellules souches derivees du tissu adipeux pour la regeneration tissulaire et la cicatrisation de plaies | |
WO2006018836A3 (fr) | Constructions d'acides nucleiques et cellules, et methodes faisant appel a ces dernieres pour modifier la fonction electrophysiologique de tissus excitables | |
EP2361303B8 (fr) | Cellule souche de type stromale multipotente isolée de glomérules humains adultes (hgl-msc), son procédé de préparation et ses utilisations en médecine régénérative du rein | |
WO2005123123A3 (fr) | Reprogrammation therapeutique, cellules souches hybrides et maturation | |
EP1806801A4 (fr) | Séparateur à pile à combustible et procédé de fabrication dudit séparateur | |
WO2006127152A3 (fr) | Procedes de production et d'utilisation de lymphocytes t regulateurs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2567692 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005723204 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 3609/KOLNP/2006 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 179927 Country of ref document: IL Ref document number: 2007527196 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 447.06 Country of ref document: BZ Ref document number: 2005253923 Country of ref document: AU Ref document number: 200580018783.5 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006147263 Country of ref document: RU |
|
ENP | Entry into the national phase |
Ref document number: 2005253923 Country of ref document: AU Date of ref document: 20050216 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005253923 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2005723204 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0511889 Country of ref document: BR |